| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $180.4M | +48.3% |
| Cost of Revenue | $175.4M | +57.0% |
| Gross Profit | $5.0M | -49.9% |
| R&D Expense | $16.9M | +48.0% |
| SG&A Expense | $38.5M | +71.0% |
| Operating Income | -$79.2M | -95.2% |
| Net Income | -$82.7M | -123.0% |
| EPS (Basic) | -$2.10 | -72.1% |
| EPS (Diluted) | -$2.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281.3M | +267.5% |
| Accounts Receivable | $57.4M | +180.8% |
| Inventory | $22.5M | +88.0% |
| Current Assets | $369.7M | +229.6% |
| Total Assets | $643.4M | +251.7% |
| Current Liabilities | $78.9M | +116.0% |
| Total Liabilities | $196.0M | +259.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.4M | -406.8% |
| Capital Expenditures | $178.0M | +1191.7% |
| Investing Cash Flow | -$178.0M | -1191.7% |
| Financing Cash Flow | $478.4M | +417.3% |
| Free Cash Flow | -$272.4M | -740.5% |
| -72.1% |
| Stockholders' Equity |
| $447.4M |
| +248.4% |